Burleson & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $5.91K | Hold |
320
| – | – | ﹤0.01% | 288 |
|
|
2022
Q3 | $9K | Hold |
320
| – | – | ﹤0.01% | 279 |
|
|
2022
Q2 | $4K | Hold |
320
| – | – | ﹤0.01% | 298 |
|
|
2022
Q1 | $6K | Hold |
320
| – | – | ﹤0.01% | 290 |
|
|
2021
Q4 | $5K | Hold |
320
| – | – | ﹤0.01% | 293 |
|
|
2021
Q3 | $9K | Hold |
320
| – | – | ﹤0.01% | 256 |
|
|
2021
Q2 | $9K | Hold |
320
| – | – | ﹤0.01% | 265 |
|
|
2021
Q1 | $9K | Buy |
+320
| New | +$9K | ﹤0.01% | 261 |
|